Prevention of early sudden cardiac death after myocardial infarction using the wearable cardioverter defibrillator - results from a real-life cohort

3 April 2022 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Ursula Rohrer

Medical University of Graz, Graz (Austria)

6 More presentations in this session

Presentation thumbnail

Device-detected sleep-disordered breathing predicts implantable defibrillator therapy in patients with heart failure

Doctor A. Mazza (Orvieto, IT)

Presentation thumbnail

Implantable cardioverter-defibrillator therapy in the very young - Patient characteristics procedural outcome and one-year follow-up - A subgroup analysis of the german DEVICE registry

Doctor D. Chung (Hamburg, DE)

Abstract Slides

Presentation thumbnail

Age-related differences and associated outcomes of S-ICD: insights from a large, european, multicenter, real-world registry

Doctor M. Schiavone (Milan, IT)

Abstract Slides

Presentation thumbnail

Real-world survival of model-3501 subcutaneous implantable defibrillator lead

Doctor F. Migliore (Padova, IT)

Presentation thumbnail

Procedure related complications following implantation of cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) devices - Insights from the German DEVICE registry

Doctor L. Kaiser (Hamburg, DE)

Abstract Slides

Access the full session

Session thumbnail

Moderated ePosters - Variety of news on device therapy

The Event

Event poster

EHRA 2022

3 April - 5 April 2022

You may be interested in

Congress Session

Ventricular storm (2)

Congress Presentation

When to consider device therapy in HFrEF - discussion

Congress Presentation

Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources